Appeal No. 1996-0605
Application 07/989,593
DECISION ON APPEAL
This is a decision on the appeal under 35 U.S.C. § 134 from the
examiner’s final rejection of claims 8, 11, 14 and 23-32, which are all the claims
pending in the application.
Claims 8 and 11 are illustrative of the subject matter on appeal and are
reproduced below:
8. A method of delivering non-enzymatic antioxidants, comprising
administering to a site in need thereof an effective amount of a free radical
quenching composition comprising a liposome containing distributed within said
liposome at least two members selected from the group consisting of beta-
carotene, vitamin E, vitamin C, glutathione, and niacin, optionally at least one
trace metal, and optionally a pharmaceutically acceptable carrier; wherein said
administering is intravenously, intraarterially, intraperitoneally, subcutaneously,
intramuscularly, intraarticularly, intracerebrally; intracerebellarly, intrabronchially,
or intrathecally; whereby the level of said non-enzymatic antioxidants of said site
is increased.
11. A method of increasing the level of antioxidants in a cell of a
mammal, comprising administering to said mammal in need thereof an effective
amount to increase the level of antioxidants in a cell of a mammal of a free
radical quenching composition comprising a liposome containing distributed
within said liposome at least two members selected from the group consisting of
beta-carotene, vitamin E, vitamin C, glutathione, and niacin, optionally at least
one trace metal, and optionally a pharmaceutically acceptable carrier; wherein
said administering is intravenously, intraaterially, intraperitoneally,
subcutaneously, intramuscularly, intraarticularly, intracerebrally, intracerebellarly
intrabronchially, or intrathecally.
The references relied upon by the examiner are:
2
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 Next
Last modified: November 3, 2007